Skip to main content
Clinical Trials/NCT04244721
NCT04244721
Recruiting
N/A

Effectiveness of PACT Intervention, Delivered by Parents, Guided by Videoconference, on the Autism of Their Children With ASD

Hôpital le Vinatier1 site in 1 country212 target enrollmentJune 30, 2020

Overview

Phase
N/A
Intervention
Not specified
Conditions
Autism Spectrum Disorder
Sponsor
Hôpital le Vinatier
Enrollment
212
Locations
1
Primary Endpoint
Autism severity
Status
Recruiting
Last Updated
9 months ago

Overview

Brief Summary

Autism Spectrum Disorder (ASD) is a neuro-developmental disorders. There are different types of interventions. Among these interventions Early Start Denver Model (ESDM) and Preschool Autism Communication Therapy (PACT) have proved efficacy at short and long term. PACT is the therapy with the highest evidences when Parents delivered the intervention themselves.

Detailed Description

In PACT, parents are guided, generally in face to face, by a professional to improve the synchrony and communication with their children with ASD. Then, it is recommended to the parents to practice the therapy daily at home. In France, this type of early intervention is poorly developed and is only accessible in specialized centers located in large urban centers. Guiding parents by videoconferencing could make this intervention accessible to families in undeserved areas. The objective of this study is to evaluate the effectiveness of a PACT intervention delivered by parents and guided by videoconferencing, on the autism in their children with ASD, aged 18 to 36 months at the inclusion. This is a mixed (quantitative and qualitative), multicenter, controlled, randomized, open-label study, comparing a group of children receiving usual care and one of whose parents is trained and accompanied by videoconferencing to developmental techniques as described in the PACT, to a group of children benefiting only from the usual care provided by the community. The primary endpoint was the severity of autism measured with the ADOS-2 (2012 Autism Diagnostic Observation Schedule) severity score (CSS) at 12 months. A total of 212 children will be included in the study (106 / group).

Registry
clinicaltrials.gov
Start Date
June 30, 2020
End Date
August 1, 2026
Last Updated
9 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Hôpital le Vinatier
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Child with autism Spectrum disorder
  • Symptoms in autism with a severity superior to 4 as measure by ADOS-2
  • Positive ADI (Autism Diagnostic Interview)
  • Diagnostic done by a multidisciplinary team
  • Nonverbal IQ above 12 months Having health assurance

Exclusion Criteria

  • For the child
  • Child with a twin brother or sister with ASD or having a brother or sister already included in this study
  • Epilepsy requiring medication
  • Severe hearing or visual impairment
  • Identification of a genetic anomaly causes participation in the intervention or validity of the data (determined by the principal investigator on a case-by-case basis)
  • For the parents
  • Severe hearing or visual impairment
  • Severe psychiatric disorder
  • Unstable somatic disorders preventing intervention
  • Lack of Internet access

Outcomes

Primary Outcomes

Autism severity

Time Frame: 12 months

Change between baseline and 12 months in the overall raw score at ADOS-2 (Autism Diagnostic Observation Schedule version 2), Module 1

Secondary Outcomes

  • Social Interactions of the child(6 and 12 months)
  • Parent-child synchrony and initiative in communication(6 and 12 months)
  • Number of words produced by the child(12 months)
  • Adaptative behavior(12 months)
  • Autism Family Experience(12 months)
  • Characteristics of the parents(12 months)

Study Sites (1)

Loading locations...

Similar Trials